Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-19 Tousignant Jennifer Chief Legal Officer Sale −4,212 $24.50 $103K 0
2026-08-19 Tousignant Jennifer Chief Legal Officer Exercise or conversion +10,000 $14.41 $144K 10,000
2026-08-19 Tousignant Jennifer Chief Legal Officer Sale −10,000 $24.50 $245K 0
2026-08-19 Tousignant Jennifer Chief Legal Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 114,072
2026-08-14 Tripuraneni Radhika Chief Medical Officer Exercise or conversion +40,000 $13.21 $528K 40,000
2026-08-14 Tripuraneni Radhika Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 0
2026-07-01 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-07-01 Ajer Jeffrey Robert Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-07-01 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-07-01 Gheuens Sarah Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-07-01 Kiselak Tomas Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-07-01 Morris Arlene Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2026-05-11 Fairmount Funds Management LLC Director Purchase +1,176,470 $17.00 $20.0M 5,090,928
2026-03-03 Harmon Seth Chief Financial Officer Shares withheld for taxes −2,031 $30.19 $61K 7,850
2026-03-03 Beetham Thomas W. Chief Operating Officer Shares withheld for taxes −3,048 $30.19 $92K 13,361
2026-03-03 Tousignant Jennifer Chief Legal Officer Shares withheld for taxes −1,675 $30.19 $51K 3,494
2026-03-03 Mahoney Stephen F. President and CEO Shares withheld for taxes −7,408 $30.19 $224K 33,349
2026-03-03 Tousignant Jennifer Chief Legal Officer Exercise or conversion +5,169 5,169
2026-03-03 Tousignant Jennifer Chief Legal Officer Shares withheld for taxes −1,724 $29.32 $51K 3,445
2026-03-03 Tousignant Jennifer Chief Legal Officer Exercise or conversion · Restricted Stock Units −5,169 15,510

Page 1 of 18 · 346 trades